ATE549421T1 - Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2 - Google Patents

Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2

Info

Publication number: ATE549421T1
Authority: AT; Austria
Prior art keywords: hiv; detecting; nucleic acids; kits; compositions
Prior art date: 2003-12-19

Application number

AT10170927T

Other languages

English (en)

Inventor

Jeffrey M Linnen

Wen Wu

Original Assignee

Gen Probe Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-19

Filing date

2004-12-16

Publication date

2012-03-15

2004-12-16 Application filed by Gen Probe Inc filed Critical Gen Probe Inc

2012-03-15 Application granted granted Critical

2012-03-15 Publication of ATE549421T1 publication Critical patent/ATE549421T1/de

Links

208000031886 HIV Infections Diseases 0.000 title abstract 3
241000713772 Human immunodeficiency virus 1 Species 0.000 title abstract 3
241000713340 Human immunodeficiency virus 2 Species 0.000 title abstract 3
108020004707 nucleic acids Proteins 0.000 title abstract 3
150000007523 nucleic acids Chemical class 0.000 title abstract 3
102000039446 nucleic acids Human genes 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
230000003321 amplification Effects 0.000 abstract 2
238000009396 hybridization Methods 0.000 abstract 2
238000003199 nucleic acid amplification method Methods 0.000 abstract 2
239000000523 sample Substances 0.000 abstract 2
108091034117 Oligonucleotide Proteins 0.000 abstract 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
AIDS & HIV (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT10170927T 2003-12-19 2004-12-16 Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2 ATE549421T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53118303P	2003-12-19	2003-12-19
US58470604P	2004-06-30	2004-06-30

Publications (1)

Publication Number	Publication Date
ATE549421T1 true ATE549421T1 (de)	2012-03-15

Family

ID=34713785

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT10170927T ATE549421T1 (de)	2003-12-19	2004-12-16	Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
AT04815024T ATE478968T1 (de)	2003-12-19	2004-12-16	Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT04815024T ATE478968T1 (de)	2003-12-19	2004-12-16	Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2

Country Status (9)

Country	Link
US (3)	US7255996B2 (de)
EP (2)	EP1694871B1 (de)
JP (1)	JP4699384B2 (de)
AT (2)	ATE549421T1 (de)
AU (1)	AU2004303886B2 (de)
CA (1)	CA2547750C (de)
DE (1)	DE602004028862D1 (de)
ES (1)	ES2383947T3 (de)
WO (1)	WO2005061738A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9175353B2 (en)	2008-11-14	2015-11-03	Gen-Probe Incorporated	Compositions, kits and methods for detection of campylobacter nucleic acid
DK2890814T3 (da)	2012-08-30	2019-12-16	Gen Probe Inc	Flerfaset nukleinsyreamplificering
CA2999029A1 (en) *	2015-09-18	2017-03-23	Siemens Healthcare Diagnostics Inc.	Reagents and methods for analysis of hiv
WO2017147585A1 (en)	2016-02-26	2017-08-31	Arizona Board Of Regents On Behalf Of Arizona State University	Synthetic translation-sensing riboswitches and uses thereof
WO2018027177A1 (en) *	2016-08-04	2018-02-08	Arizona Board Of Regents On Behalf Of Arizona State University	Loop-mediated synthetic riboregulators

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US186219A (en) *		1877-01-16		Improvement in grafting-machines
US91985A (en) *		1869-06-29		Improvement in tobacco-presses
US235835A (en) *		1880-12-21		Alfred wilbue
US49604A (en) *		1865-08-29		Improvement in buildings for preserving milk, fruit
FR2422956A1 (fr)	1978-04-13	1979-11-09	Pasteur Institut	Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
US6001977A (en)	1984-08-22	1999-12-14	The United States Of America As Represented By The Department Of Health And Human Services	Cloning and expression of HTLV-III DNA
US4965188A (en)	1986-08-22	1990-10-23	Cetus Corporation	Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4868105A (en)	1985-12-11	1989-09-19	Chiron Corporation	Solution phase nucleic acid sandwich assay
US5310651A (en)	1986-01-22	1994-05-10	Institut Pasteur	DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2
US4839288A (en)	1986-01-22	1989-06-13	Institut Pasteur	Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
AU601397B2 (en)	1986-01-22	1990-09-13	Institut Pasteur	Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents
US20030186219A1 (en)	1986-01-22	2003-10-02	Institut Pasteur Of Paris	Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
US6544728B1 (en)	1986-01-22	2003-04-08	Institut Pasteur	Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2
US5580739A (en)	1986-01-22	1996-12-03	Institut Pasteur	Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
ATE88762T1 (de)	1986-08-11	1993-05-15	Siska Diagnostics Inc	Methoden und zusammensetzungen fuer tests mit nukleinsaeuresonden.
US5541308A (en)	1986-11-24	1996-07-30	Gen-Probe Incorporated	Nucleic acid probes for detection and/or quantitation of non-viral organisms
IL86724A (en)	1987-06-19	1995-01-24	Siska Diagnostics Inc	Methods and kits for amplification and testing of nucleic acid sequences
CA1340843C (en)	1987-07-31	1999-12-07	J. Lawrence Burg	Selective amplification of target polynucleotide sequences
US5283174A (en)	1987-09-21	1994-02-01	Gen-Probe, Incorporated	Homogenous protection assay
US6031091A (en)	1987-09-21	2000-02-29	Gen-Probe Incorporated	Non-nucleotide linking reagents for nucleotide probes
US5585481A (en)	1987-09-21	1996-12-17	Gen-Probe Incorporated	Linking reagents for nucleotide probes
US5639604A (en)	1987-09-21	1997-06-17	Gen-Probe Incorporated	Homogeneous protection assay
US5124246A (en)	1987-10-15	1992-06-23	Chiron Corporation	Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5130238A (en)	1988-06-24	1992-07-14	Cangene Corporation	Enhanced nucleic acid amplification process
US5118801A (en)	1988-09-30	1992-06-02	The Public Health Research Institute	Nucleic acid process containing improved molecular switch
JP3276955B2 (ja)	1988-09-30	2002-04-22	ジーン−トラック・システムス	Ｒｎａの鋳型の末端に結合したプローブ構造およびその使用方法
EP1715064B1 (de) *	1989-06-02	2009-02-25	Institut Pasteur	Nukleotid-Sequenzen von HIV-1, HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur Amplifizierung von pol-Sequenzen dieser Retroviren und zur In Vitro Diagnostik von diesen Viren verursachten Infektionen
FR2647810B1 (fr)	1989-06-02	1994-07-22	Pasteur Institut	Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
US5656207A (en)	1989-06-24	1997-08-12	Gen Probe Incorporated	Detecting or quantifying multiple analytes using labelling techniques
CA2020958C (en)	1989-07-11	2005-01-11	Daniel L. Kacian	Nucleic acid sequence amplification methods
US5856088A (en)	1989-07-11	1999-01-05	Gen-Probe Incorporated	Detection of human immunodeficiency virus type 1
ATE147792T1 (de)	1989-11-30	1997-02-15	Pharmacia Biotech Ab	Neues verfahren zum nachweis einer spezifischen nukleinsäuresequenz in einer zellprobe
US5455166A (en)	1991-01-31	1995-10-03	Becton, Dickinson And Company	Strand displacement amplification
WO1992016180A2 (en) *	1991-03-13	1992-10-01	Siska Diagnostics, Inc.	Detection of 3'-azido-3'-deoxythymidine resistance
ATE257860T1 (de)	1991-08-02	2004-01-15	Biomerieux Bv	Quantifikation von nukleinsäuren
KR940703846A (ko)	1991-12-24	1994-12-12	비. 린네 파샬	갭(gap)이 형성된 2′ 변성된 올리고뉴클레오티드(gapped 2′ modifed oligonucleotides)
JP4137996B2 (ja)	1992-05-06	2008-08-20	ジェン−プローブ・インコーポレイテッド	核酸配列増幅方法，組成物及びキット
CA2141430C (en)	1992-08-04	2009-05-12	Sherrol H. Mcdonough	Nucleic acid sequence amplification
DK0591914T4 (da)	1992-10-06	2010-05-25	Siemens Healthcare Diagnostics	Retrovirus fra HIV-gruppen og dets anvendelse
WO1994023069A1 (en)	1993-03-26	1994-10-13	Gen-Probe Incorporated	Detection of human immunodeficiency virus type 1
WO1995003430A1 (en)	1993-07-23	1995-02-02	Gen-Probe Incorporated	Methods for enhancing nucleic acid amplification
US5925517A (en)	1993-11-12	1999-07-20	The Public Health Research Institute Of The City Of New York, Inc.	Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5591578A (en)	1993-12-10	1997-01-07	California Institute Of Technology	Nucleic acid mediated electron transfer
US5824473A (en)	1993-12-10	1998-10-20	California Institute Of Technology	Nucleic acid mediated electron transfer
US5827648A (en)	1995-12-13	1998-10-27	Chiron Corporation	Differential hybridization for relative quantification of variant populations
US6187538B1 (en)	1993-12-13	2001-02-13	Bayer Corporation	Differential hybridization for relative quantification of variant populations
DE4405810A1 (de)	1994-02-23	1995-08-24	Behringwerke Ag	Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6169169B1 (en)	1994-05-19	2001-01-02	Dako A/S	PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis
CN1651457B (zh)	1994-10-20	2010-07-28	巴斯德研究所	Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
EP0709466B1 (de)	1994-10-28	2006-09-27	Gen-Probe Incorporated	Zusammensetzungen und Verfahren für die gleichzeitige Detektion und Quantifizierung von einer Mehrheit spezifischer Nuklein Säure Sequenzen
US5599662A (en)	1995-02-17	1997-02-04	Hoffmann-La Roche Inc.	Oliconucleotide primers and probes for the detection of HIV-1
DE19513152A1 (de)	1995-04-07	1996-10-10	Bundesrep Deutschland	Verwendung eines "Immundefizienzvirus-supprimierenden Lymphokins (ISL)" zur Hemmung der Virusvermehrung, insbesondere von Retroviren
US5731148A (en)	1995-06-07	1998-03-24	Gen-Probe Incorporated	Adduct protection assay
DE69836012T2 (de)	1997-05-02	2007-04-05	Gen-Probe Inc., San Diego	Zwei-schritt hybridisierung und einfang von einem polynukleotid
US6013459A (en)	1997-06-12	2000-01-11	Clinical Micro Sensors, Inc.	Detection of analytes using reorganization energy
US5962665A (en)	1997-06-16	1999-10-05	Abbott Laboratories	Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en)	1997-06-25	1999-12-14	Ortho Clinical Diagnostics, Inc.	Amplification and detection of HIV-1 and/or HIV 2
ES2330812T3 (es)	1998-07-02	2009-12-15	Gen-Probe Incorporated	Antorchas moleculares.
US6303293B1 (en)	1999-02-02	2001-10-16	Ortho-Clinical Diagnostics, Inc.	Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof
US6623919B1 (en)	1999-02-03	2003-09-23	Ortho-Clinical Diagnostics, Inc	Oligonucleotide primers for efficient multiplex detection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and methods of use thereof
EP1026236A1 (de)	1999-02-04	2000-08-09	Dsm N.V.	Auxotrophe Stämme zur Sekundärstoffwechselprodukt-Biosynthese
ATE456677T1 (de)	1999-07-09	2010-02-15	Gen Probe Inc	Hiv-1 detektion mittels nukleinsäureamplifizierung
US6770752B2 (en)	2001-01-09	2004-08-03	Becton, Dickinson And Company	Sequences for detection of HIV-1
AU2002244641A1 (en) *	2001-01-11	2002-07-24	Innogenetics N.V.	Method for detection of drug-induced mutations in the hiv reverse transcriptase gene
EP1513958B1 (de)	2002-06-14	2011-08-10	Gen-Probe Incorporated	Zusammensetzungen zum nachweis von hepatitis-b-virus

2004
- 2004-12-16 US US11/015,605 patent/US7255996B2/en not_active Expired - Lifetime
- 2004-12-16 EP EP04815024A patent/EP1694871B1/de not_active Expired - Lifetime
- 2004-12-16 AT AT10170927T patent/ATE549421T1/de active
- 2004-12-16 CA CA2547750A patent/CA2547750C/en not_active Expired - Lifetime
- 2004-12-16 DE DE602004028862T patent/DE602004028862D1/de not_active Expired - Lifetime
- 2004-12-16 JP JP2006545572A patent/JP4699384B2/ja not_active Expired - Fee Related
- 2004-12-16 EP EP10170927A patent/EP2251442B9/de not_active Expired - Lifetime
- 2004-12-16 ES ES10170927T patent/ES2383947T3/es not_active Expired - Lifetime
- 2004-12-16 AU AU2004303886A patent/AU2004303886B2/en not_active Expired
- 2004-12-16 WO PCT/US2004/042899 patent/WO2005061738A1/en not_active Ceased
- 2004-12-16 AT AT04815024T patent/ATE478968T1/de not_active IP Right Cessation
2007
- 2007-08-13 US US11/837,954 patent/US7666600B2/en not_active Expired - Lifetime
2010
- 2010-01-21 US US12/691,413 patent/US8318432B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE602004028862D1 (de)	2010-10-07
AU2004303886A1 (en)	2005-07-07
JP4699384B2 (ja)	2011-06-08
CA2547750A1 (en)	2005-07-07
US20100190149A1 (en)	2010-07-29
EP2251442B9 (de)	2012-04-25
EP1694871B1 (de)	2010-08-25
US20050153282A1 (en)	2005-07-14
ATE478968T1 (de)	2010-09-15
US7255996B2 (en)	2007-08-14
CA2547750C (en)	2014-04-08
EP1694871A1 (de)	2006-08-30
US20080020398A1 (en)	2008-01-24
US8318432B2 (en)	2012-11-27
ES2383947T3 (es)	2012-06-27
EP2251442B1 (de)	2012-03-14
AU2004303886B2 (en)	2009-09-03
US7666600B2 (en)	2010-02-23
JP2007515960A (ja)	2007-06-21
EP2251442A1 (de)	2010-11-17
WO2005061738A1 (en)	2005-07-07

Publication	Publication Date	Title
EP1513958A4 (de)	2006-05-17	Zusammensetzungen und verfahren zum nachweis von hepatitis-b-virus
ATE550441T1 (de)	2012-04-15	Verfahren, zusammensetzungen und kits zur isothermischen amplifikation von nukleinsäuren
DE602005024234D1 (de)	2010-12-02	Neue primer und sonden zum nachweis von parvovirus b19
FI3891300T3 (fi)	2023-05-10	Menetelmät spatiaalista analyysiä varten rna-templatoitua ligaatiota käyttäen
DE60009323D1 (de)	2004-04-29	Methoden und zusammensetzungen zur linearen isothermalen amplifikation von polynukleotidsequenzen
DE60132924D1 (de)	2008-04-03	Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
DE60034396D1 (de)	2007-05-31	Reaktionsgemisch und Verfahren für RT-PCR mittels einer homopolymeren Nukleinsäure
EP1845160A4 (de)	2009-07-01	Nukleotidsequenz-amplifikationsverfahren
EP1735465A4 (de)	2008-03-12	Zusammensetzungen zur verwendung bei der bestimmung von hämorrhagischen fieberviren
DE69233083D1 (de)	2003-07-03	Primers und Sondern zum Nachweis von Hepatitis C
ATE485391T1 (de)	2010-11-15	Zusammensetzungen, methoden und testssysteme zur bestimmung der präsenz von cryptosporidium organismen in einer testprobe
DE60309817D1 (de)	2007-01-04	Dopplezweck -Primer und -Proben für verbesserte Hybridisierungsassays durch Zerstörung von Sekundärstrukturen
EP1641936A4 (de)	2007-10-24	Verfahren zur genomamplifikation
DE60328098D1 (de)	2009-08-06	Polynukleotide zum nachweis und zur quantifizierung von hepatitis-b-virus-nukleinsäuren
ATE549421T1 (de)	2012-03-15	Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
WO2007076493A8 (en)	2017-02-02	Methods and reagents for genotyping hcv
DE69616102D1 (de)	2001-11-29	Amplikationsprimern und Nukleinsäuresonden zum Nachweis von Coccidioides immites
DE60330160D1 (de)	2009-12-31	Oligonukleotide zur Detektion von Hepatitis B Viren
ATE420975T1 (de)	2009-01-15	Methode zur linearen nicht-selektiven amplifikation von nukleinsäuren
ATE547520T1 (de)	2012-03-15	Verfahren zum nachweis und zur quantifizierung von endogener weizen-dna-sequenz
ATE452996T1 (de)	2010-01-15	Nachweis von hiv-typen und hiv-subtypen
ATE490342T1 (de)	2010-12-15	Zusammensetzungen und verfahren zum nachweis von streptokokken der gruppe b
DE602005023586D1 (de)	2010-10-28	Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv
ATE307906T1 (de)	2005-11-15	Verfahren zum nachweis von gram-positiven bakterien
ATE394510T1 (de)	2008-05-15	Verfahren zum nachweis und/oder zur identifizierung von bakterien des genus staphylococcus